cognitive cybersecurity intelligence

News and Analysis

Search

New patent expiration for Optinose Us drug XHANCE

Xhance, a drug marketed by Optinose US Inc, has fourteen patents. It has a total of 293 patent family members spanning across 29 countries. The generic ingredient in Xhance is fluticasone propionate, which has one listed supplier.

Source: www.drugpatentwatch.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts